NASDAQ · Financial Statements

Ocular Therapeutix, Inc. (OCUL) Financial Statements

$7.51 NASDAQ: OCUL Market Cap $1.64B

Ocular Therapeutix, Inc. most recently reported annual revenue of $52.0M, net profit of $-266.0M, revenue has compounded at 25.1% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20212022202320242025
Revenue$44.0M$51.0M$58.0M$64.0M$52.0M
Operating Profit$-78.0M$-79.0M$-82.0M$-172.0M$-270.0M
Net Profit$-7.0M$-71.0M$-81.0M$-194.0M$-266.0M
EPS$-0.98$-0.97$-1.02$-1.22$-1.42
Op Margin-179.3%-152.7%-141.0%-269.6%-521.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$205.0M$149.0M$252.0M$458.0M$808.0M
Total Liabilities$117.0M$114.0M$161.0M$143.0M$154.0M
Cash$164.0M$102.0M$196.0M$392.0M$737.0M
Borrowings$59.0M$64.0M$83.0M$76.0M$80.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-66.0M$-60.0M$-70.0M$-135.0M$-205.0M
Investing Cash Flow$-2.0M$-7.0M$-12.0M$-3.0M$-24.0M
Financing Cash Flow$2.0M$1.0M$-5.0M$-301.0M$0
Net Cash Flow$-64.0M$-62.0M$94.0M$196.0M$345.0M
Free Cash Flow$-67.0M$-63.0M$-76.0M$-136.0M$-217.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.49
EV / EBITDA-4.25
FCF Yield-14.76%
Quick Ratio13.03
Interest Coverage-27.53
Return 1Y-27.55%
Return 3Y94.28%
Return 5Y-29.84%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
OCUL Overview OCUL Dividend Run Stock Screener